| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.035 | 0.8 |